Healthcare & Life Sciences
Kalaris Therapeutics
United Stateswww.allovir.com/
Kalaris Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Kalaris Therapeutics
Kalaris Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing an engineered dual-targeting biologic, TH103, aimed at improving anti-VEGF treatment durability and outcomes for retinal diseases including neovascular age-related macular degeneration.
Explore Kalaris Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.